BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, April 23, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2014
View Archived Issues
Overcoming limitations imposed by the BBB using peptide-drug conjugation
Read More
Pharmacosmos presents data on iron isomaltoside 1000 for the treatment of iron deficiency and IBD
Read More
Abide Therapeutics establishes strategic collaboration with Celgene in inflammation and immunology
Read More
The antitumor efficacy of disrupting tumor metabolism by targeting mitochondrial function
Read More
Engineered agrin fragment improves disorders involving NMJs dysfunction
Read More
Researchers at Merck & Co. design new ROR-gammaT antagonists
Read More
Roche designs new XIAP inhibitors for cancer
Read More
Genervon's GM-604 receives FDA orphan drug designation for ALS
Read More
Former Envoy Therapeutics discloses novel GPR6 receptor ligands
Read More
Cumberland Pharmaceuticals acquires drug for hyponatremia
Read More
Isis Pharmaceuticals earns milestone for advancing ISIS-TTRRx
Read More
Arrowhead cleared to begin phase IIa trial of ARC-520 in Hong Kong
Read More
Titan Pharmaceuticals and FDA discuss path forward for Probuphine
Read More
Global phase III trial of LR-769 begins in patients with hemophilia A and B
Read More
Chugai Pharmaceuticals conducting two phase III trials of SA-237
Read More
Transition Therapeutics and Perrigo modify ELND-005 agreement
Read More
FDA grants fast track designation to GLYX-13
Read More
IntelGenx and RedHill Biopharma respond to FDA Complete Response Letter on VersaFilm NDA
Read More
Combination of ABT-263 and GDC-0941 could provide a novel therapeutic regimen for GBM
Read More
Intra-Cellular Therapies begins phase I/II trial of ITI-007
Read More
Phase II trial of emricasan initiated in NAFLD
Read More
Seattle Genetics presents data on Adcetris in Hodgkin's lymphoma
Read More
Chimerix presents new data on brincidofovir
Read More
Genomind presents data in support of Genecept Assay
Read More
Alexion gives update on NICE draft guidance for Soliris in England
Read More